SCHEMBL17198

SCHEMBL17198

c1cnc2[nH]ccc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31010424 1.00
Hydrochloric Acid SCHEMBL1935427 0.97 MAPK1 (0.95)
Hydrochloric Acid SCHEMBL28232771 0.97 MAPK1 (0.95)
Tetrahydrofuran SCHEMBL27800780 0.84 MAPK1 (0.70)
SCHEMBL2548188 0.75 MAPK1 (0.56)
SCHEMBL22970755 0.69 MAPK1 (0.50)
SCHEMBL329638 0.69
SCHEMBL31434925 0.67 MAPK1 (0.50)
SCHEMBL26038410 0.67 MAPK1 (0.50)
SCHEMBL18207739 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4648763-A2 COMPOUNDS FOR FGFRS INHIBITORS Cogent Biosciences, Inc. (US) 2025-11-19 EP claimed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 WO claimed
US-20240270741-A1 COMPOUNDS FOR FGFRS INHIBITORS COGENT BIOSCIENCES, INC. 2024-08-15 US claimed
WO-2024151638-A2 COMPOUNDS FOR FGFRS INHIBITORS COGENT BIOSCIENCES, INC. (US) 2024-07-18 WO claimed
CN-112218631-B Heterocyclic inhibitors of ATR kinase 德州大学系统董事会 2023-12-22 CN claimed
EP-3765008-B1 HETEROCYCLIC INHIBITORS OF ATR KINASE UNIV TEXAS (US) 2023-06-07 EP claimed
US-20220127276-A1 PYRAZINE DERIVATIVE AND APPLICATION THEREOF IN INHIBITING SHP2 SUZHOU GENHOUSE PHARMACEUTICAL CO., LTD (CN) 2022-04-28 US claimed
CN-114195799-A Pyrazine derivative and application thereof in inhibition of SHP2 勤浩医药(苏州)有限公司 2022-03-18 CN claimed
EP-3936502-A1 PYRAZINE DERIVATIVE AND APPLICATION THEREOF IN INHIBITING SHP2 Suzhou Genhouse Pharmaceutical Co., Ltd. (CN) 2022-01-12 EP claimed
CN-113474338-A Pyrazine derivative and application thereof in inhibition of SHP2 勤浩医药(苏州)有限公司 2021-10-01 CN claimed
US-6528227-B2 Radiation-sensitive black-and-white silver halide photographic material in contact with screen sheets designed to emit electrons when exposed to X-rays with an energy greater than or equal to 10 kVp; radiology AGFA-GEVAERT (BE) 2003-03-04 US claimed
US-20020076640-A1 Film/screen system and image-forming system for use in direct X-ray applications AGFA-GEVAERT (BE) 2002-06-20 US claimed
EP-1195641-A1 Film/Screen system and image-forming system for use in direct X-ray applications Agfa-Gevaert (BE) 2002-04-10 EP claimed
EP-1181282-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-02-27 EP claimed
WO-2000075139-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2000-12-14 WO claimed
EP-0534323-B1 Process for the preparation of high chloride tabular grain emulsions (II) EASTMAN KODAK CO (US) 1997-05-14 EP claimed
US-5391468-A With emulsion layer containing blend of spectrally sensitized tabular iodohalide grains and second, slower, fine grain population of higher solubility silver salt content having second dye adsorbed to surface EASTMAN KODAK COMPANY (US) 1995-02-21 US claimed
US-5389509-A Surface treatment of grains with an organonitrogen compound EASTMAN KODAK COMPANY (US) 1995-02-14 US claimed
EP-0534323-A1 Process for the preparation of high chloride tabular grain emulsions (II) EASTMAN KODAK COMPANY (US) 1993-03-31 EP claimed
US-5178997-A A fused N-heterocyclic compound as a grain growth modifier; materials handling EASTMAN KODAK COMPANY (US) 1993-01-12 US claimed